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Abstract The c-AMP-responsive element binding pro-
tein (CREB) and its phosphorylated product (P-CREB) are
nuclear proteins expressed after stimulation of pain-pro-
ducing areas of the spinal cord. There is evidence indi-
cating that central sensitization within dorsal horn neurons
is dependent on P-CREB transcriptional regulation. The
objectives of the study were to investigate the expression of
P-CREB in cells in rat trigeminal nucleus caudalis after
noxious stimulation and to determine whether pre-treat-
ment with speciﬁc anti-migraine agents modulate this
expression. CREB and P-CREB labelling was investigated
within the trigeminal caudalis by immunohistochemistry
after capsaicin stimulation. Subsequently, the effect of i.v.
pre-treatment with either sumatriptan (n = 5), or nara-
triptan (n = 7) on P-CREB expression was studied. Five
animals pre-treated with i.v. normal saline were served as
controls. CREB and P-CREB labelling was robust in all
animal groups within Sp5C. Both naratriptan and suma-
triptan decreased P-CREB expression (p = 0.0003 and
0.0013) within the Sp5C. Triptans attenuate activation of
CREB within the central parts of the trigeminal system,
thereby leading to potential inhibition of central sensiti-
zation. P-CREB may serve as a new marker for post-syn-
aptic neuronal activation within Sp5C in animal models
relevant to migraine.
Keywords CREB  Sumatriptan  Naratriptan 
Capsaicin  Migraine  Sensitization
Introduction
The c-AMP-responsive element binding protein (CREB) is
a transcription factor that regulates the expression of genes
important for adaptive neuronal responses [1] as well as
complex functions such as learning and memory [2]. Upon
extracellular stimuli multiple kinases, such as protein
kinase A, protein kinase C and casein kinase II, phos-
phorylate CREB at serine 133 (P-CREB) leading to acti-
vation of immediate early gene c-fos [3, 4]. Fos protein
expression can then be used as a marker of neuronal acti-
vation within brainstem and spinal nociceptive pathways
[5]. CREB also target other genes, such as brain-derived
neurotrophic factor (BDNF), that is signiﬁcantly involved
in depression, serving as potential marker for treatment
together with P-CREB [6].
Like c-fos, CREB signalling is also involved in pain
processing, e.g. at the level of spinal cord in a study of
tissue injury-induced inﬂammation and hyperalgesia [7].
Likewise, at the brainstem level, in vitro evidence suggests
that P-CREB within the rat trigeminal ganglion is regulated
by calcitonin gene-related peptide (CGRP) induced by
activation of either the adenosine A1 receptor or the P2X3
receptor [8, 9]. In addition, it has been proposed that
inhibition of CREB prior to its nuclear translocation may
prevent the slowly developing onset of sensitization within
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sensitization within the dorsal root neurons is mediated via
P-CREB-mediated transcriptional regulation [10].
Allodynia has been recognized in migraine since the
nineteenth century [11], with clinic- [12] and population-
[13] based studies showing that it is seen in about two-
thirds of patients. Allodynia is a clinical reﬂection of
sensitization, and both central and peripheral sensitization
are important insofar as they both inﬂuence attacks and
perhaps disease progression [14, 15]. Sensitization of
peripheral trigeminovascular neurons that innervate the
meninges may be crucial for the development of throbbing
in the initial phase of migraine following by sensitization
of central trigeminal neurons within the trigeminal nucleus
caudalis [16]. In previous work, sumatriptan did not change
P-CREB induced by forskolin in cultured neurons taken
from adult rat trigeminal ganglions, nor inhibit CGRP
release at the same model, as may expected [8], although
the role of CGRP on sensitization is unclear [17]. An
interesting question remains as to whether triptans modu-
late phosphorylation of CREB within neurons of the tri-
geminal nucleus caudalis in vivo. We, therefore, mapped
P-CREB expression within rat trigeminal nucleus caudalis
after capsaicin stimulation of the trigeminovascular system,
and determined the effect of triptans, serotonin 5-HT1B/1D
receptor agonists. We show capsaicin stimulation of the
trigeminal system activates P-CREB within trigeminal
nucleus caudalis and both sumatriptan and naratriptan
inhibit induced P-CREB at doses relevant to clinical
practice.
Methods
Male Sprague–Dawley rats (240–300 g) were housed
under diurnal lighting and allowed food and water ad libi-
tum. All experiments were conducted consistent with the
UK Home Ofﬁce Animals (Scientiﬁc Procedures) Act
(1986).
CREB and P-CREB mapping
with immunohistochemistry
Eight rats were anaesthetized with pentobarbital i.p.
(60 mg/kg) and the femoral vein was cannulated for
physiology and drug treatments. Ten minutes later two rats
were killed (intact animals), whereas a craniotomy was
performed in the remaining six animals. After craniotomy
0.1, 1 or 10 lM capsaicin in a cotton ball was directly
applied onto the right middle meningeal artery (MMA) for
5 min (n = 2 for each capsaicin dose). Ten minutes after
the end of stimulation period, the animals were killed by
pentobarbital (100 mg/kg, i.v.) and perfused with PBS
followed by paraformaldehyde. Brainstems were removed
and kept in 30% sucrose until sectioning in a freezing
microtome (5 lm) followed by immunohistochemistry
(avidin–biotin procedure).
Several dilutions of P-CREB and CREB antibodies (Cell
Signalling Technology, cat# 9191 and 9192, respectively)
were tested to establish 1:100 as optimal. Biotinylated
sheep anti-rabbit serum (vector) served as a secondary
antibody (1:600). Tissues from two non-stimulated animals
were used as controls. The brainstems from two other intact
animals, where only anaesthesia followed by killing was
performed after 30 min, were processed for immunohisto-
chemistry to study the effect of surgery on CREB and
P-CREB expression at a comparable timing. Two addi-
tional animals were treated as above following exactly the
same procedure but killed 2 h after capsaicin stimulation
(1 lM). Their brainstems were prepared for fos protein
immunohistochemistry at the level of the trigeminal
nucleus caudalis [18] to determine if the stimulation was
sufﬁcient to activate the trigeminal neurons. Although we
refer to the labelling as CREB and P-CREB we cannot
exclude cross-reactivity of the antibody so that CREB-like
and P-CREB-like may be better terms.
Pharmacological studies
The effect of i.v. pre-treatment with either sumatriptan
1m gk g
-1 (n = 5), or naratriptan 1 mg kg
-1 (n = 7) on
P-CREB expression within Sp5C was studied following the
above described procedure. Five animals pre-treated with
i.v. normal saline given at the same volume as the drugs
served as controls.
Physiology
Physiological monitoring was carried out in all animals,
including arterial pressure (MABP), heart rate (HR) and
rectal temperature.
CREB and P-CREB immunoreactive cell counting
(image analysis method)
Images were acquired using a Zeiss Axiolab microscope
(Carl Zeiss GmbH Jena, Germany) with a mechanical
stage, ﬁtted with a Sony-iris CCD videocamera (Sony
Corp. Tokyo, Japan). The video camera was connected to a
PC (Pentium IV-based) loaded with appropriate image
analysis software (Sigma Scan Pro 5.0, Science, Germany).
Slides were examined at a magniﬁcation 940. More spe-
ciﬁcally, in each case the cellular area of the trigeminal
nucleus caudalis was selected according to the atlas of
Paxinos and Watson [19] and then the number of P-CREB
immunostaining cells were calculated via a semiautomatic
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software. Prototypes of positively stained neurons were
carefully selected by an expert (DDM) and then labelled
cells were counted within the pre-deﬁned areas by the
software automatically. Counting was performed by an
investigator blind to drug treatment (NK). Twelve coronal
sections of the trigeminal nucleus caudalis were selected
for counting from each animal; four consecutive slides at
the obex level, four at level -2 mm and other four at the
level -6 mm (C2) [20]. The mean number was calculated
and used for statistics for each animal.
Results
Blood pressure and heart rate (not shown) did not differ
between animals, except that both the animals treated with
high capsaicin dose (10 lM) died.
CREB and P-CREB mapping
with immunohistochemistry
In the intact animals CREB but not P-CREB induction
was detected bilaterally within all parts of trigeminal
nucleus caudalis (data not shown). After craniotomy,
CREB was detected bilaterally within almost all the
brainstem nuclei including the trigeminal nucleus cauda-
lis, solitary tract, area postrema, lateral reticular nucleus,
inferior olive nucleus, within all the laminae. P-CREB
was not detected within the trigeminal nucleus caudalis.
At the dose of 1 lM of capsaicin CREB labelling
increased in all the above-mentioned nuclei and P-CREB
labelling was found as well within the ipsilateral side of
trigeminal nucleus caudalis laminae I and II (5–30 cells
per section within the obex and the rostal parts down to
C2 level). Neurons in lamina X were labelled as well,
whereas only a few contralateral neurons were labelled at
laminae I, II. Capsaicin 0.1 lM induced weak P-CREB
labelling in cells within laminae I and II (1–5 neurons per
section) (Fig. 1). Fos protein-labelled neurons were
observed within Sp5C laminae I and II 2 h after 1 lmol
capsaicin stimulation. Fos labelling was robust and clear.
After capsaicin stimulation (0.1 and 1 lM) one animal
died in each dose (mortality rate 10%). Therefore, the
dose of 1 lM of capsaicin was selected for consecutive
drug testing.
Pharmacological studies
Pre-treatment with i.v. sumatriptan and naratriptan at a
dose of 1 mg kg
-1 signiﬁcantly decreased capsaicin-
induced P-CREB expression within laminae I and II
of trigeminal nucleus caudalis compared to vehicle
pre-treated animals (Figs. 2, 3). Two treated animals died
(mortality rate 10.5%). The physiological data were not
different between three groups (data not shown).
0.1µmol capsaicin x10 
1µmol capsaicin                                       x10
10µmol capsaicin            x10 
Fig. 1 Micro-photographs show P-CREB expression within the rat
trigeminal nucleus caudalis (Sp5C) after capsaicin stimulation (obex).
Capsaicin applied onto the middle meningeal artery (MMA) for 5 min
at three different doses (1, 0.1 and 10 lM, n = 2 for each dose).
P-CREB-labelled neurons are shown (arrows) within the rat trigem-
inal nucleus caudalis (obex) 10 min after the end of stimulation.
Avidin–biotin immunohistochemistry
J Headache Pain (2011) 12:411–417 413
123Discussion
We show here that stimulation of the peripheral parts of the
rat trigeminovascular system, ﬁrst-order trigeminal neu-
rons, by capsaicin-induced CREB phosphorylation within
the second-order neurons at the brainstem in the trigeminal
nucleus caudalis. To our knowledge, this is the ﬁrst in vivo
study mapping the CREB and P-CREB expression within
the trigeminal nucleus caudalis after noxious stimulus.
Furthermore, the anti-migraine drugs sumatriptan and
naratriptan prevented brainstem CREB activation.
Methodological limitations
Preabsorption controls for anti-CREB and anti-P-CREB
were not performed, to prove their speciﬁcity to the protein
using the exact immunohistochemical protocol except for
the addition of the immunizing peptide. However, we fol-
lowed the manufacturer’s immunohistochemical protocols
and the P-CREB labelling distribution within the pain-
producing areas of the trigeminal system supports the
speciﬁcity of the antibodies used. Several time points for
CREB and P-CREB expression were not tested to see if the
10-min window was optimal for drug testing. We followed
suggestions based on previous experiments [7, 21] showing
that this time window, 10 min after stimulation of MMA to
observe phosphorylation of CREB within trigeminal
nucleus caudalis, was appropriate. The mortality rate was
slightly high (10%) but acceptable. Finally, a TRPV1
antagonist could be used to show a reverse effect. We
tested only one dose of triptans, not several to show a
possible dose–response related effect. Also the effect of
triptans to inhibit other stimuli (mechanical distension or
thermal stimuli or other chemical stimuli) was not studied.
CREB and P-CREB mapping within the trigeminal
system
Capsaicin 1 lmol applied on the MMA-induced P-CREB
immunohistochemistry within the ipsilateral brain stem
trigeminal nucleus caudalis, as it has been shown with c-fos
[5]. P-CREB within Sp5C was relatively pain-speciﬁc
because of the particular distribution within the laminae I
and II, that was clear for counting and with good signal to
noise for drug testing. Physiological monitoring showed
that the microsurgical procedure and the capsaicin stimu-
lation were tolerated well by the pentobarbital anaesthe-
tized rats. Previous in vitro experiments showed P-CREB
expression within the rat trigeminal ganglion neurons
induced by forskolin [8]. Recently, activation of CREB
30
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Fig. 2 Treatment with both sumatriptan and naratriptan attenuates
CREB activation within trigeminal nucleus caudalis. Sumatriptan
(n = 5) and naratriptan (n = 7) at a dose of 1 mg kg
-1 i.v.
signiﬁcantly decreased capsaicin (1 lmol) induced P-CREB expres-
sion within trigeminal nucleus caudalis compared to vehicle treated
animals (n = 5)
A B
Dug vehicle + capsaicin
x10  Sumatriptan+ capsaicin                x10  
Fig. 3 Micro-photographs show P-CREB expression within the rat
trigeminal nucleus caudalis (Sp5C) after capsaicin stimulation and
sumatriptan treatment (obex). Normal saline (n = 5) or sumatriptan
1m gk g
-1 (n = 5) was i.v. administered in rats and 10 min later
1 lM capsaicin applied onto the middle meningeal artery (stimulation
lasted for 5 mins). Ten minutes after the end of stimulation the
animals were killed and preceded for immunohistochemistry (avidin–
biotin procedure). Panel A sample from a vehicle ? capsaicin-treated
animal. Panel B sample from a sumatriptan ? capsaicin-treated
(1 mg kg
-1) animal. P-CREB labelled neurons are shown (arrows)
within the rat trigeminal nucleus caudalis (obex)
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123within mouse cultured trigeminal ganglion neurons was
seen after treatment with CGRP via Ca
2?-dependent
mechanisms [9]. We had the opportunity to look for CREB
and P-CREB expression within the ipsilateral trigeminal
ganglia after capsaicin stimulation; we did not observe
P-CREB. Apparently the CREB cascade exists in rat tri-
geminal ganglion cells, although how to induce it in vivo
still remains unclear and needs further investigation.
Triptan effects on P-CREB within trigeminal nucleus
caudalis
Both sumatriptan and naratriptan prevented capsaicin-
induced P-CREB within the trigeminal nucleus caudalis
as previously shown with capsaicin-induced c-fos [22, 23]
indicating that the P-CREB approach yields similar data.
At the ﬁrst neuron level, however, in vitro studies failed
to show an effect of sumatriptan on forskolin-induced
CREB activation [8], suggesting that sumatriptan triggers
the suppressive transcriptional cascade only within the
central parts of the trigeminal system, not in the periph-
ery. No such model for c-fos exists to compare to, since
c-fos is not expressed within trigeminal ganglion cells [5].
To better explore the effect of triptans on P-CREB, two
drugs with somewhat different pharmacological properties
have been tested: the hydrophilic sumatriptan, which does
not penetrate the blood brain barrier in normal circum-
stances, and the tenfold more lipophilic naratriptan [24].
Because both drugs share almost similar afﬁnity to 5-HT1
receptors, we used the same doses for both drugs. The
clinically relevant doses are different although this may
be simply a matter of absorption. Both triptans attenuated
P-CREB regardless of their differences. It is important,
however, to understand the molecular mechanism of the
action of triptans on neurons. Triptans not only increase
intracellular Ca
2? leading in inhibition of CGRP gene
transcription [25, 26], but also down regulate gene tran-
scription generally within trigeminal nucleus caudalis
cells by blocking CREB phosphorylation and c-fos
expression, resulting in depression of brainstem nocicep-
tive neurons, as has been shown using electrophysiolog-
ical methods [27, 28]. These ﬁndings may partially
explain the effect of triptans on the central sensitization
process seen in migraine.
Central sensitization and P-CREB
It has been speculated that triptans can successfully abort
migraine as long as central sensitization still depends on
incoming signals from the periphery, but not after central
sensitization becomes self-sufﬁcient [29]. Since this
hypothesis still lacks good documentation, it would be
interesting to test the effect of triptans in vivo within the
trigeminal ganglion neurons. However, only electrophysi-
ological studies can be performed, and these techniques are
limited to short lasting neuronal alterations. One of the
aims of this study was to explore an in vivo approach to
investigate the longer time course effects of triptans within
both trigeminal ganglion and trigeminal nucleus caudalis
neurons, such as effects on gene transcription. Unfortu-
nately trigeminal ganglion cells did not show sufﬁcient
labelling to explore this question further. Yet, the ﬁndings
of our study may serve as vehicle to better understand the
effect of triptans on slowly developing central sensitization
within trigeminal nucleus caudalis.
Gene transcription is crucial for long lasting neuronal
changes triggered by several extracellular signals. In the
case of CREB, multiple molecules or proteins, such as
CGRP [9], lead to its phosphorylation, via activation of
several kinases [1, 30–32]. After phosphorylation CREB
activates other immediate early genes like c-fos, molecules
important for synaptic function like brain-derived neuro-
trophic factor and neuronal nitric oxide [33], which are all
involved in pain transmission. Thus, selective blocking of
CREB activation before its nuclear translocation would be
important in inhibiting pain signalling acutely and also in
blocking the sensitization cascade triggered by P-CREB,
therefore reducing escalation of pain signalling [9]. In other
words this would be pivotal for reducing the escalation/
persistence of pain due to central sensitization, such as in
migraine. In addition, P-CREB may also serve as marker of
neuronal presynaptic activation within the trigeminovas-
cular system in animal models of migraine biology, like fos
protein.
C-fos and P-CREB as markers for trigeminal caudalis
activation in animal models of migraine biology
C-fos encodes a nuclear protein that regulates the tran-
scription of other target genes and of its one promoter. Its
detection within the brainstem and spinal cord neurons is
the best studied technique to map the postsynaptic noci-
ceptive pathways in numerous cephalic pain models [5, 18,
34]. In the ﬁeld of migraine research fos protein immu-
noreactivity offers a method to identify subpopulations of
neurons activated in response to noxious stimuli and
identify related nociceptive pathways [5]. The majority of
studies have employed this technique to map neuronal
activation not only throughout the trigeminovascular sys-
tem [35–39], but also higher structures involved in the
ascending and descending modulatory control of pain [6,
40–42], thus, greatly enhancing our understanding of the
pathophysiology of migraine. As with other models of the
components of migraine the use of fos expression has
certain limitations [43]. The major one being the model can
only be as good as the stimulus since it is the stimulus that
J Headache Pain (2011) 12:411–417 415
123drives the expression of fos protein. Several intracranial
structures have been stimulated chemically or electrically
to induce fos within trigeminal nucleus caudalis, including
the meninges [18, 20, 22, 23], trigeminal ganglion [44], the
superior sagittal sinus [35] and middle meningeal artery
[45]. It seems that the activation of speciﬁc structures of
the trigeminovascular system (e.g. the superior sagittal
sinus) leads to more clinically relevant conclusions [35,
46]. It is noteworthy that induction of fos to quantiﬁable
levels requires a strong consistent stimulation that is often
not physiological [47, 48]. It must also be remembered that
c-fos is not expressed in all neurons as with the dorsal root
ganglion cells [34], thus, lack of fos protein expression
does not equate to lack of neuronal activity. Technical
difﬁculties in inducing c-fos expression within trigeminal
nucleus caudalis are also important [49]. One ﬁnal limita-
tion of the model is seen via direct activation of the an-
tinociceptive descending pathways, which elicits c-fos
expression in spinal neurons even in the absence of any
nociceptive input [50].
P-CREB on the other hand displays several advantages
over c-fos as a neuronal marker of post-synaptic activation
within trigeminal nucleus caudalis. So far, activation of
CREB within the trigeminal nucleus caudalis, or trigeminal
ganglion in vitro, has been seen only after speciﬁc acti-
vation of nociceptive neurons, thus P-CREB within lami-
nae I and II seems to be a direct effect of the noxious
stimulus used. In addition, the time window needed for
phosphorylation of CREB is much shorter, up to 10 min,
compared to 120 min needed for c-fos expression, leading
potentially to lower animal mortality rates. Although only
stimulation of middle meningeal artery has been used,
theoretically all the other parts of the peripheral trigeminal
system can be used to induce P-CREB. The fact that
P-CREB expression has been detected within trigeminal
ganglion, although only in vitro, raises new possibilities for
pharmaocological studies within both the peripheral and
central parts of the trigeminal system. Further investigation
is required though to induce and map P-CREB in trigem-
inal ganglion cells in vivo.
Conclusions
P-CREB is a transcriptional factor involved in sensitization
of nociceptive cells. Noxious stimulation of peripheral
parts of the trigeminal system induces P-CREB within
trigeminal nucleus caudalis. Triptans inhibit this activation.
Thus, triptans might prevent central sensitization by
attenuating P-CREB-mediated transcriptional pathways. In
addition, P-CREB may serve as a new marker for post-
synaptic neuronal activation within trigeminal nucleus
caudalis in animal models of migraine biology.
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